Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch (15662 1596 2 Pouch Labeling Sept 2022)

Pouch (15662 1596 2 Pouch Labeling Sept 2022)
The text is a label of a medication named "Lidocaine HCL Injection". It provides information on the concentration of the medication, lot number, and dosage instructions. It also includes a warning that it is for "RXONLY" or prescription-only use.*
FDA Label Image

Case (15662 1596 3 Case Labeling Sept 2022)

Case (15662 1596 3 Case Labeling Sept 2022)
This is a description of a medication called 4% Lidocaine HCL Injection, USP, which comes in a case of 25. The medication has a concentration of 48mg/mL and is intended for prescription use only. The text includes storage information and a label number but does not provide further details on how the medication should be used.*
FDA Label Image

Rfid (51662 1596 3 Serialized Rfid Labeling Sept 2022)

FDA Label Image

Amp (Amp Label Sept 2022)

Amp (Amp Label Sept 2022)
This is a prescription-only single-dose solution for topical use and retrobulbar injection. It contains 200 mg/5 mL (40 mg/mL) of an unmentioned drug and is preservative-free. It is distributed by Hospira, Inc. from Lake Forest, IL, USA. The lot number is HH-HHH-AA, and it has an expiration date of DMMMYYYY. The rest of the text is not legible.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
This is a list of different categories of drugs and some examples of each category, such as nitrates/nitrites (including nitric oxide, nitroglycerin, nitroprusside, nitrous oxide), local anesthetics (including articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine and tetracaine), antineoplastic agents (including cyclophosphamide, flutamide, hydroxyurea, ifosfamide and rasburicase), antibiotics (including dapsone, nitrofurantoin, para-aminosalicylic acid, and sulfonamides), antimalarials (including chloroquine and primaquine), anticonvulsants (including phenobarbital, phenytoin, and sodium valproate), and other drugs (including acetaminophen, metoclopramide, quinine, and sulfasalazine).*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.